English
简体中文
Total: £ 56.28
Published Date: 2025-04-23 | Pages: 119 | Tables: 117 | Medical Care
The global Competent Cells market size was US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
The global Competent Cells market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
By Type: (Dominant Segment vs High-Margin Innovation)
Chemically Competent Cells
Electrocompetent Cells
By Application: (Core Demand Driver vs Emerging Opportunity)
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid Creation
Cre-Lox Recombination (PIR1/PIR2)
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Merck KGaA in Europe)
- Emerging Product Trends: Chemically Competent Cells adoption vs. Electrocompetent Cells premiumization
- Demand-Side Dynamics: Subcloning & Routine Cloning growth in China vs. Phage Display Library Construction potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Competent Cells market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Electrocompetent Cells in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Phage Display Library Construction in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Competent Cells value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Competent Cells Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Competent Cells Revenue Market Share by Region (2020-2025)
2.4 Global Competent Cells Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Competent Cells Market Size and Prospective (2020-2031)
2.5.2 Europe Competent Cells Market Size and Prospective (2020-2031)
2.5.3 China Competent Cells Market Size and Prospective (2020-2031)
2.5.4 Japan Competent Cells Market Size and Prospective (2020-2031)
2.5.5 India Competent Cells Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Competent Cells Historic Market Size by Type (2020-2025)
3.2 Global Competent Cells Forecasted Market Size by Type (2026-2031)
3.3 Different Types Competent Cells Representative Players
4 Breakdown Data by Application
4.1 Global Competent Cells Historic Market Size by Application (2020-2025)
4.2 Global Competent Cells Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Competent Cells Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Competent Cells Players by Revenue (2020-2025)
5.1.2 Global Competent Cells Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Competent Cells Revenue
5.4 Global Competent Cells Market Concentration Analysis
5.4.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2024
5.5 Global Key Players of Competent Cells Head office and Area Served
5.6 Global Key Players of Competent Cells, Product and Application
5.7 Global Key Players of Competent Cells, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Competent Cells Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Competent Cells Market Size by Type (2020-2025)
6.1.2.2 North America Competent Cells Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Competent Cells Market Size by Application (2020-2025)
6.1.3.2 North America Competent Cells Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Competent Cells Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Competent Cells Market Size by Type (2020-2025)
6.2.2.2 Europe Competent Cells Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Competent Cells Market Size by Application (2020-2025)
6.2.3.2 Europe Competent Cells Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Competent Cells Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Competent Cells Market Size by Type (2020-2025)
6.3.2.2 China Competent Cells Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Competent Cells Market Size by Application (2020-2025)
6.3.3.2 China Competent Cells Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Competent Cells Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Competent Cells Market Size by Type (2020-2025)
6.4.2.2 Japan Competent Cells Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Competent Cells Market Size by Application (2020-2025)
6.4.3.2 Japan Competent Cells Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments and Downstream
6.5.1 India Competent Cells Revenue by Company (2020-2025)
6.5.2 India Market Size by Type
6.5.2.1 India Competent Cells Market Size by Type (2020-2025)
6.5.2.2 India Competent Cells Market Share by Type (2020-2025)
6.5.3 India Market Size by Application
6.5.3.1 India Competent Cells Market Size by Application (2020-2025)
6.5.3.2 India Competent Cells Market Share by Application (2020-2025)
6.5.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Company Details
7.1.2 Merck KGaA Business Overview
7.1.3 Merck KGaA Competent Cells Introduction
7.1.4 Merck KGaA Revenue in Competent Cells Business (2020-2025)
7.1.5 Merck KGaA Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Details
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Competent Cells Introduction
7.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2020-2025)
7.2.5 Thermo Fisher Scientific Recent Development
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Details
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Competent Cells Introduction
7.3.4 Agilent Technologies Revenue in Competent Cells Business (2020-2025)
7.3.5 Agilent Technologies Recent Development
7.4 Takara Bio
7.4.1 Takara Bio Company Details
7.4.2 Takara Bio Business Overview
7.4.3 Takara Bio Competent Cells Introduction
7.4.4 Takara Bio Revenue in Competent Cells Business (2020-2025)
7.4.5 Takara Bio Recent Development
7.5 Promega Corporation
7.5.1 Promega Corporation Company Details
7.5.2 Promega Corporation Business Overview
7.5.3 Promega Corporation Competent Cells Introduction
7.5.4 Promega Corporation Revenue in Competent Cells Business (2020-2025)
7.5.5 Promega Corporation Recent Development
7.6 Beijing TransGen Biotech
7.6.1 Beijing TransGen Biotech Company Details
7.6.2 Beijing TransGen Biotech Business Overview
7.6.3 Beijing TransGen Biotech Competent Cells Introduction
7.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2020-2025)
7.6.5 Beijing TransGen Biotech Recent Development
7.7 GeneScript Corporation
7.7.1 GeneScript Corporation Company Details
7.7.2 GeneScript Corporation Business Overview
7.7.3 GeneScript Corporation Competent Cells Introduction
7.7.4 GeneScript Corporation Revenue in Competent Cells Business (2020-2025)
7.7.5 GeneScript Corporation Recent Development
7.8 Yeastern Biotech
7.8.1 Yeastern Biotech Company Details
7.8.2 Yeastern Biotech Business Overview
7.8.3 Yeastern Biotech Competent Cells Introduction
7.8.4 Yeastern Biotech Revenue in Competent Cells Business (2020-2025)
7.8.5 Yeastern Biotech Recent Development
7.9 New England Biolabs
7.9.1 New England Biolabs Company Details
7.9.2 New England Biolabs Business Overview
7.9.3 New England Biolabs Competent Cells Introduction
7.9.4 New England Biolabs Revenue in Competent Cells Business (2020-2025)
7.9.5 New England Biolabs Recent Development
7.10 QIAGEN N.V.
7.10.1 QIAGEN N.V. Company Details
7.10.2 QIAGEN N.V. Business Overview
7.10.3 QIAGEN N.V. Competent Cells Introduction
7.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2020-2025)
7.10.5 QIAGEN N.V. Recent Development
7.11 OriGene Technologies
7.11.1 OriGene Technologies Company Details
7.11.2 OriGene Technologies Business Overview
7.11.3 OriGene Technologies Competent Cells Introduction
7.11.4 OriGene Technologies Revenue in Competent Cells Business (2020-2025)
7.11.5 OriGene Technologies Recent Development
7.12 Lucigen
7.12.1 Lucigen Company Details
7.12.2 Lucigen Business Overview
7.12.3 Lucigen Competent Cells Introduction
7.12.4 Lucigen Revenue in Competent Cells Business (2020-2025)
7.12.5 Lucigen Recent Development
7.13 Zymo Research
7.13.1 Zymo Research Company Details
7.13.2 Zymo Research Business Overview
7.13.3 Zymo Research Competent Cells Introduction
7.13.4 Zymo Research Revenue in Competent Cells Business (2020-2025)
7.13.5 Zymo Research Recent Development
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Company Details
7.14.2 Bio-Rad Laboratories Business Overview
7.14.3 Bio-Rad Laboratories Competent Cells Introduction
7.14.4 Bio-Rad Laboratories Revenue in Competent Cells Business (2020-2025)
7.14.5 Bio-Rad Laboratories Recent Development
7.15 Bioline
7.15.1 Bioline Company Details
7.15.2 Bioline Business Overview
7.15.3 Bioline Competent Cells Introduction
7.15.4 Bioline Revenue in Competent Cells Business (2020-2025)
7.15.5 Bioline Recent Development
7.16 Delphi Genetics
7.16.1 Delphi Genetics Company Details
7.16.2 Delphi Genetics Business Overview
7.16.3 Delphi Genetics Competent Cells Introduction
7.16.4 Delphi Genetics Revenue in Competent Cells Business (2020-2025)
7.16.5 Delphi Genetics Recent Development
7.17 IBA GmBH
7.17.1 IBA GmBH Company Details
7.17.2 IBA GmBH Business Overview
7.17.3 IBA GmBH Competent Cells Introduction
7.17.4 IBA GmBH Revenue in Competent Cells Business (2020-2025)
7.17.5 IBA GmBH Recent Development
7.18 Cell Applications
7.18.1 Cell Applications Company Details
7.18.2 Cell Applications Business Overview
7.18.3 Cell Applications Competent Cells Introduction
7.18.4 Cell Applications Revenue in Competent Cells Business (2020-2025)
7.18.5 Cell Applications Recent Development
7.19 BioDynamics Laboratory
7.19.1 BioDynamics Laboratory Company Details
7.19.2 BioDynamics Laboratory Business Overview
7.19.3 BioDynamics Laboratory Competent Cells Introduction
7.19.4 BioDynamics Laboratory Revenue in Competent Cells Business (2020-2025)
7.19.5 BioDynamics Laboratory Recent Development
7.20 Scarab Genomics
7.20.1 Scarab Genomics Company Details
7.20.2 Scarab Genomics Business Overview
7.20.3 Scarab Genomics Competent Cells Introduction
7.20.4 Scarab Genomics Revenue in Competent Cells Business (2020-2025)
7.20.5 Scarab Genomics Recent Development
7.21 GCC Biotech
7.21.1 GCC Biotech Company Details
7.21.2 GCC Biotech Business Overview
7.21.3 GCC Biotech Competent Cells Introduction
7.21.4 GCC Biotech Revenue in Competent Cells Business (2020-2025)
7.21.5 GCC Biotech Recent Development
7.22 SMOBIO Technology
7.22.1 SMOBIO Technology Company Details
7.22.2 SMOBIO Technology Business Overview
7.22.3 SMOBIO Technology Competent Cells Introduction
7.22.4 SMOBIO Technology Revenue in Competent Cells Business (2020-2025)
7.22.5 SMOBIO Technology Recent Development
7.23 Edge BioSystems
7.23.1 Edge BioSystems Company Details
7.23.2 Edge BioSystems Business Overview
7.23.3 Edge BioSystems Competent Cells Introduction
7.23.4 Edge BioSystems Revenue in Competent Cells Business (2020-2025)
7.23.5 Edge BioSystems Recent Development
8 Competent Cells Market Dynamics
8.1 Competent Cells Industry Trends
8.2 Competent Cells Market Drivers
8.3 Competent Cells Market Challenges
8.4 Competent Cells Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Competent Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Competent Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Competent Cells Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Competent Cells Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Competent Cells Revenue Share by Region (2020-2025)
Table 6. Global Competent Cells Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Competent Cells Revenue Share Forecast by Region (2026-2031)
Table 8. Global Competent Cells Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Competent Cells Revenue Market Share by Type (2020-2025)
Table 10. Global Competent Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Competent Cells Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Competent Cells Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Competent Cells Revenue Market Share by Application (2020-2025)
Table 15. Global Competent Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Competent Cells Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Competent Cells Application
Table 18. Global Competent Cells Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Competent Cells Market Share by Players (2020-2025)
Table 20. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2024)
Table 21. Ranking of Global Top Competent Cells Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Competent Cells Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Competent Cells, Headquarters and Area Served
Table 24. Global Key Players of Competent Cells, Product and Application
Table 25. Global Key Players of Competent Cells, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Competent Cells Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Competent Cells Revenue Market Share by Company (2020-2025)
Table 29. North America Competent Cells Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Competent Cells Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Competent Cells Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Competent Cells Revenue Market Share by Company (2020-2025)
Table 33. Europe Competent Cells Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Competent Cells Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Competent Cells Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Competent Cells Revenue Market Share by Company (2020-2025)
Table 37. China Competent Cells Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Competent Cells Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Competent Cells Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Competent Cells Revenue Market Share by Company (2020-2025)
Table 41. Japan Competent Cells Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Competent Cells Market Size by Application (2020-2025) & (US$ Million)
Table 43. India Competent Cells Revenue by Company (2020-2025) & (US$ Million)
Table 44. India Competent Cells Revenue Market Share by Company (2020-2025)
Table 45. India Competent Cells Market Size by Type (2020-2025) & (US$ Million)
Table 46. India Competent Cells Market Size by Application (2020-2025) & (US$ Million)
Table 47. Merck KGaA Company Details
Table 48. Merck KGaA Business Overview
Table 49. Merck KGaA Competent Cells Product
Table 50. Merck KGaA Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 51. Merck KGaA Recent Development
Table 52. Thermo Fisher Scientific Company Details
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Competent Cells Product
Table 55. Thermo Fisher Scientific Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Agilent Technologies Company Details
Table 58. Agilent Technologies Business Overview
Table 59. Agilent Technologies Competent Cells Product
Table 60. Agilent Technologies Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 61. Agilent Technologies Recent Development
Table 62. Takara Bio Company Details
Table 63. Takara Bio Business Overview
Table 64. Takara Bio Competent Cells Product
Table 65. Takara Bio Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 66. Takara Bio Recent Development
Table 67. Promega Corporation Company Details
Table 68. Promega Corporation Business Overview
Table 69. Promega Corporation Competent Cells Product
Table 70. Promega Corporation Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 71. Promega Corporation Recent Development
Table 72. Beijing TransGen Biotech Company Details
Table 73. Beijing TransGen Biotech Business Overview
Table 74. Beijing TransGen Biotech Competent Cells Product
Table 75. Beijing TransGen Biotech Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 76. Beijing TransGen Biotech Recent Development
Table 77. GeneScript Corporation Company Details
Table 78. GeneScript Corporation Business Overview
Table 79. GeneScript Corporation Competent Cells Product
Table 80. GeneScript Corporation Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 81. GeneScript Corporation Recent Development
Table 82. Yeastern Biotech Company Details
Table 83. Yeastern Biotech Business Overview
Table 84. Yeastern Biotech Competent Cells Product
Table 85. Yeastern Biotech Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 86. Yeastern Biotech Recent Development
Table 87. New England Biolabs Company Details
Table 88. New England Biolabs Business Overview
Table 89. New England Biolabs Competent Cells Product
Table 90. New England Biolabs Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 91. New England Biolabs Recent Development
Table 92. QIAGEN N.V. Company Details
Table 93. QIAGEN N.V. Business Overview
Table 94. QIAGEN N.V. Competent Cells Product
Table 95. QIAGEN N.V. Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 96. QIAGEN N.V. Recent Development
Table 97. OriGene Technologies Company Details
Table 98. OriGene Technologies Business Overview
Table 99. OriGene Technologies Competent Cells Product
Table 100. OriGene Technologies Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 101. OriGene Technologies Recent Development
Table 102. Lucigen Company Details
Table 103. Lucigen Business Overview
Table 104. Lucigen Competent Cells Product
Table 105. Lucigen Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 106. Lucigen Recent Development
Table 107. Zymo Research Company Details
Table 108. Zymo Research Business Overview
Table 109. Zymo Research Competent Cells Product
Table 110. Zymo Research Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 111. Zymo Research Recent Development
Table 112. Bio-Rad Laboratories Company Details
Table 113. Bio-Rad Laboratories Business Overview
Table 114. Bio-Rad Laboratories Competent Cells Product
Table 115. Bio-Rad Laboratories Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 116. Bio-Rad Laboratories Recent Development
Table 117. Bioline Company Details
Table 118. Bioline Business Overview
Table 119. Bioline Competent Cells Product
Table 120. Bioline Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 121. Bioline Recent Development
Table 122. Delphi Genetics Company Details
Table 123. Delphi Genetics Business Overview
Table 124. Delphi Genetics Competent Cells Product
Table 125. Delphi Genetics Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 126. Delphi Genetics Recent Development
Table 127. IBA GmBH Company Details
Table 128. IBA GmBH Business Overview
Table 129. IBA GmBH Competent Cells Product
Table 130. IBA GmBH Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 131. IBA GmBH Recent Development
Table 132. Cell Applications Company Details
Table 133. Cell Applications Business Overview
Table 134. Cell Applications Competent Cells Product
Table 135. Cell Applications Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 136. Cell Applications Recent Development
Table 137. BioDynamics Laboratory Company Details
Table 138. BioDynamics Laboratory Business Overview
Table 139. BioDynamics Laboratory Competent Cells Product
Table 140. BioDynamics Laboratory Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 141. BioDynamics Laboratory Recent Development
Table 142. Scarab Genomics Company Details
Table 143. Scarab Genomics Business Overview
Table 144. Scarab Genomics Competent Cells Product
Table 145. Scarab Genomics Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 146. Scarab Genomics Recent Development
Table 147. GCC Biotech Company Details
Table 148. GCC Biotech Business Overview
Table 149. GCC Biotech Competent Cells Product
Table 150. GCC Biotech Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 151. GCC Biotech Recent Development
Table 152. SMOBIO Technology Company Details
Table 153. SMOBIO Technology Business Overview
Table 154. SMOBIO Technology Competent Cells Product
Table 155. SMOBIO Technology Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 156. SMOBIO Technology Recent Development
Table 157. Edge BioSystems Company Details
Table 158. Edge BioSystems Business Overview
Table 159. Edge BioSystems Competent Cells Product
Table 160. Edge BioSystems Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 161. Edge BioSystems Recent Development
Table 162. Competent Cells Market Trends
Table 163. Competent Cells Market Drivers
Table 164. Competent Cells Market Challenges
Table 165. Competent Cells Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Competent Cells Product Picture
Figure 2. Global Competent Cells Market Share by Type: 2024 VS 2031
Figure 3. Chemically Competent Cells Features
Figure 4. Electrocompetent Cells Features
Figure 5. Global Competent Cells Market Share by Application: 2024 VS 2031
Figure 6. Subcloning & Routine Cloning
Figure 7. Phage Display Library Construction
Figure 8. Toxic/Unstable DNA Cloning
Figure 9. High-Throughput Cloning
Figure 10. Protein Expression
Figure 11. Mutagenesis
Figure 12. Single-Stranded DNA Production
Figure 13. Bacmid Creation
Figure 14. Cre-Lox Recombination (PIR1/PIR2)
Figure 15. Competent Cells Report Years Considered
Figure 16. Global Competent Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Competent Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Competent Cells Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Competent Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Competent Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. China Competent Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Japan Competent Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. India Competent Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Global Competent Cells Market Share by Players in 2024
Figure 25. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2024
Figure 27. North America Competent Cells Market Share by Type (2020-2025)
Figure 28. North America Competent Cells Market Share by Application (2020-2025)
Figure 29. Europe Competent Cells Market Share by Type (2020-2025)
Figure 30. Europe Competent Cells Market Share by Application (2020-2025)
Figure 31. China Competent Cells Market Share by Type (2020-2025)
Figure 32. China Competent Cells Market Share by Application (2020-2025)
Figure 33. Japan Competent Cells Market Share by Type (2020-2025)
Figure 34. Japan Competent Cells Market Share by Application (2020-2025)
Figure 35. India Competent Cells Market Share by Type (2020-2025)
Figure 36. India Competent Cells Market Share by Application (2020-2025)
Figure 37. Merck KGaA Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 38. Thermo Fisher Scientific Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 39. Agilent Technologies Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 40. Takara Bio Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 41. Promega Corporation Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 42. Beijing TransGen Biotech Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 43. GeneScript Corporation Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 44. Yeastern Biotech Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 45. New England Biolabs Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 46. QIAGEN N.V. Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 47. OriGene Technologies Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 48. Lucigen Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 49. Zymo Research Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 51. Bioline Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 52. Delphi Genetics Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 53. IBA GmBH Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 54. Cell Applications Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 55. BioDynamics Laboratory Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 56. Scarab Genomics Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 57. GCC Biotech Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 58. SMOBIO Technology Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 59. Edge BioSystems Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
